G40 I63
Conditions
Interventions
Group 1: Healthy subjects: standard routine MRI protocol, as well as additional randomized execution of individual MR sequences including motion correction.
Group 2: Patients with epilepsy, acute stro
Sponsors
Abteilung Neuroradiologie, Uniklinik Freiburg
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Healthy controls 18 years or older and patients with no age limit, that are able to consent. In patients not able to consent the consent of a parent or legal guardian is required. a) Healthy subjects 18 years and older for the pilot phase b) Patients in the 9.5 hour time window of acute stroke c) Patients with no age limit for evaluation of epileptogenic focus. d) Paediatric patients with an indication for clinical routine mri and existing signed consent from a parent or legal guardian.
Exclusion criteria
Exclusion criteria: Contraindication for MRI as stated in the written informed consent (for example pacemaker, medical pumps or pregnancy).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical assesment of a new optical motion tracking system within the MRI diagnostic routine. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the quality of MR images using a new optical motion tracking system to minimize motion artifacts in intra-individual comparison with conventional MR imaging. | — |
Countries
Germany
Contacts
Public ContactKarl Egger
Abteilung Neuroradiologie, Uniklinik Freiburg
Outcome results
None listed